| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | HLTH |
| | ADVZ 2022-1 (EUR 175m) | Advanz Pharma Corp (fka Concordia Healthcare Corp) | | EMEA | Jan 19, 2022 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| SUE | 353.000 | 9.80 | Jun-03 | Wa. Wxyzaxn | D3 | F- | P+ | Lsgbp | C | - | 99.00-99.25 | 539 | 5% | - | 10.23800 |
Tranche Comments 6.25 al: Redemption: 2024-04-01; Registration: 144X/Cun K; Comments: EUX175b(xxmsfix oxqb EUX150b) hzx qo 475b 5% Yxx 2028 (QH 4/24, 50/25/xzx) qbx 7QH3qx KKQ XioK/144Y. V3/V-/V+. LK(bioh/V&K), VVm Vzxh/MK/CLC/VVL/Vioo/XVH. Tzbf 99.00-99.25, KVM 99.25 zxiz (+/-0.125) oqx xxxix 175b, hzbi 99.375 / V+539 qm 0.5% 2/28; Deal Comments QZO150b ykv al QZO475b 5% vus 4/01/2028. Use of Proceeds Bevekcg Xjkbjkcpe Zjkbjfef |
|
|
